Science Explorer Back to mapMap
Discussion
Researcher · Samsung Medical Center · South Korea

Myung‐Ju Ahn

Myung‐Ju Ahn publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Lung Cancer Diagnosis and Treatment.

ORCID 0000-0002-5740-9654 OpenAlex
World rank
#52,419
of 7,710,434 ranked researchers
Rank in South Korea
#203
of 162,609
Works
1,307
Citations
75k
Citations per work
57.5
h-index
112
i10-index 543Top 0.1% in Pulmonary and Respiratory Medicine
Myung‐Ju Ahn

What does Myung‐Ju Ahn research?

Myung‐Ju Ahn's work is mostly in Medicine (71%), Biochemistry, Genetics and Molecular Biology (12%).

Health Sciences: 932 works · 71.3% of their workMedicine: 932 works · 71.3% of their workPulmonary and Respiratory Medicine: 447 works · 34.2% of their workOncology: 365 works · 27.9% of their workSurgery: 68 works · 5.2% of their workRadiology, Nuclear Medicine and Imaging: 52 works · 4.0% of their workEverything else: 222 works · 17.0% of their workLife Sciences: 153 works · 11.7% of their workBiochemistry, Genetics and Molecular Biology: 153 works · 11.7% of their workMolecular Biology: 86 works · 6.6% of their workCancer Research: 67 works · 5.1% of their workTHEIR WORKMyung‐Ju Ahn1,307works
Life Sciences12%Health Sciences71%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine93271.3%
  2. Everything else22217.0%
    1. Biochemistry, Genetics and Molecular Biology15311.7%
  1. 1Pulmonary and Respiratory Medicine34% of their works
  2. 2Oncology28% of their works
  3. 3Molecular Biology7% of their works
  4. 4Surgery5% of their works
  5. 5Cancer Research5% of their works
  6. 6Radiology, Nuclear Medicine and Imaging4% of their works

Research topics

Which keywords describe Myung‐Ju Ahn's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Radiotherapy, Genomic Profiles and Small-Cell Lung Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Targeted Therapy1,0113 topics
  2. Clinical Trials8842 topics
  3. Chemotherapy7174 topics
  4. ALK Inhibitors5921 topic
  5. EGFR Mutations5921 topic
  6. Radiotherapy3082 topics
  7. Genomic Profiles2921 topic
  8. Small-Cell Lung Cancer2921 topic
  9. CT Screening2311 topic
  10. Lung Cancer2311 topic
  11. Immune Checkpoint Blockade2081 topic
  12. PD-1 and PD-L12081 topic
  13. Cetuximab1942 topics
  14. Precision Medicine1852 topics
  15. Cancer Genomics1271 topic
  16. Mutational Signatures1271 topic
  17. Fluorouracil1171 topic
  18. KRAS Mutations1171 topic
  19. Human Papillomavirus771 topic
  20. Oropharyngeal Cancer771 topic
  21. Medical Imaging681 topic
  22. Radiomics681 topic

Where does Myung‐Ju Ahn work?

Myung‐Ju Ahn's main affiliation in the publication record is Samsung Medical Center, South Korea.

How many publications and citations does Myung‐Ju Ahn have?

OpenAlex counts 1,307 works and 75,201 citations for Myung‐Ju Ahn, an h-index of 112, ranking #52,419 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Myung‐Ju Ahn

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Myung‐Ju Ahn. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.